Long-Term Cardiomyopathy Risk Varies by Chemo Agent

Decreased risk seen for daunorubicin versus doxorubicin among survivors of childhood cancer

Source link

Related posts

Role of Vitamin-D Deficiency in Term Neonates with Late-Onset Sepsis: A Case–Control Study


Hydrogels with Flexible Electronics Herald New Medical Possibilities


Second Deadly Risk; Oncologist Shortage; Searching for Cancer in a Haystack


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy